Benzene, (3,3-dimethylbutoxy)- | 15673-06-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: Benzene, (3,3-dimethylbutoxy)-
• 英文别名: 3,3-dimethylbutoxybenzene
• CAS: 15673-06-0
• 化学式: C₁₂H₁₈O
• 分子量: 178.27
• InChiKey: ZBISMGLJTXKLQV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• Cathepsin K inhibitors
  申请人：Bamberg Timothy Joe

  公开号：US20070032484A1

  公开（公告）日：2007-02-08

  The present invention provides a compound of the Formula: a pharmaceutically acceptable salt, a solvate, or a prodrug thereof, wherein m, n, Ar 1 , R 1 , R 2 , R 3 , R 4 , and R 5 are those defined herein. The present invention also provides methods for using and preparing compounds of Formula I.

  本发明提供了一种公式的化合物： 其药学上可接受的盐、溶剂合物或前药，其中m、n、Ar 1 、R 1 、R 2 、R 3 、R 4 和R 5 如本文所定义。本发明还提供了使用和制备公式I化合物的方法。
• Diaryl piperidines as CB1 modulators
  申请人：Scott D. Jack

  公开号：US20070203183A1

  公开（公告）日：2007-08-30

  A compound having the general structure of Formula (I): or a pharmaceutically acceptable salt, solvate, or ester thereof, are useful in treating diseases, disorders, or conditions such as metabolic syndrome (e.g., obesity, waist circumference, lipid profile, and insulin sensitivity), neuroinflammatory disorders, cognitive disorders, psychosis, addictive behavior, gastrointestinal disorders, and cardiovascular conditions.

  具有通式（I）的一种化合物，或其药学上可接受的盐、溶剂合物或酯，可用于治疗代谢综合征（例如肥胖、腰围、脂质谱和胰岛素敏感性）、神经炎症性疾病、认知障碍、精神病、成瘾行为、胃肠道疾病和心血管疾病等疾病、疾病或症状。
• Fused Heterocyclic Compounds as Ion Channel Modulators
  申请人：Kobayashi Tetsuya

  公开号：US20120010192A1

  公开（公告）日：2012-01-12

  The present disclosure relates to compounds that are sodium channel inhibitors and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes. In particular embodiments, the structure of the compounds is given by Formula I: wherein R 1 , R 2 , R 3 , R 4 , and R 5 are as described herein, to methods for the preparation and use of the compounds and to pharmaceutical compositions containing the same.

  本公开涉及一类是钠通道抑制剂的化合物，以及它们在治疗各种疾病状态中的应用，包括心血管疾病和糖尿病。在特定实施例中，该类化合物的结构由式I给出：其中R1、R2、R3、R4和R5如本文所述，以及制备和使用该类化合物的方法，以及含有这些化合物的药物组合物。
• Pharmaceutically acceprable salts of aporphine compounds of carboxyl group-containing agents and methods for preparing the same
  申请人：Fan Chin-Tsai

  公开号：US20090318488A1

  公开（公告）日：2009-12-24

  The present invention discloses novel pharmaceutically acceptable salts of aporphine compounds and carboxyl-group containing agents. Also, the present invention discloses methods for preparing the pharmaceutically acceptable salts. These pharmaceutically acceptable salts are suitable for use in treating and/or preventing hyperglycemic disease and/or several oxidative stress related diseases.

  本发明揭示了阿波啶化合物和含羧基的试剂的新型药用可接受盐。此外，本发明还揭示了制备药用可接受盐的方法。这些药用可接受盐适用于治疗和/或预防高血糖病和/或几种与氧化应激相关的疾病。
• Amorphous Amides
  申请人：Xerox Corporation

  公开号：US20150105587A1

  公开（公告）日：2015-04-16

  An amorphous amide compound of the formula wherein R is selected from the group consisting of an alkyl group, an aryl group, an alkylaryl group, an arylalkyl group, and combinations thereof. An amorphous diamide compound of the formula wherein R 1 is selected from the group consisting of an alkylene group, an arylene group, an alkylarylene group, an arylalkylene group, and combinations thereof.

  一个无定形的酰胺化合物的化学式，其中R从包括烷基、芳基、烷基芳基、芳基烷基及其组合的群体中选择。一个无定形的二酰胺化合物的化学式，其中R1从包括亚烷基、亚芳基、烷基亚芳基、芳基烷亚基及其组合的群体中选择。